Pharma’s Visit to the Plastic Surgeon

Pharmaceutical Executive magazine has just published the third of Heartbeat CEO Bill Drummy’s four-part series on the disruptive, industry-changing force he calls the "Speed of Change."

In the first piece in the series, he painted a picture of this radically important movement that the industry has been mostly missing.

His second column explored the necessary reinvention of pharma’s sales and marketing model.

Now, in this third installment, titled "Pharma’s Visit to the Plastic Surgeon", he contends that the creation of conglomerate pharma cos, or ‘super-pharmas’, has slowed the industry to a crawl. These oversized, sluggish companies need to pare down to their essential, vital cores.

You can read the column in the November issue of the magazine, or just click here to see on PharmExec.com >

Source: Bill Drummy, as published in Pharmaceutical Executive Magazine
Date Published: November, 2011